In recent years, the AfMET region has attracted greater attention in the pharmaceutical industry, mainly due to its growing market size and population.

AfMET will remain one of the most attractive markets due to:

  1. Significant government spending on healthcare
  2. A young and fast-growing population
  3. Increased coverage and health insurance
  4. Increasing private investment in healthcare sector
  5. Opportunities from Sub-Optimal healthcare structures in certain markets

Saudi Arabia, Turkey, Algeria, Iraq, Egypt, South Africa and the UAE are some of the major markets in the region.